
About Akamara Biomedicine
Akamara Biomedicine was a Healthcare company based in India founded in 2019. It develops innovative therapeutics for cancer treatment. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Therapeutics and Cancer Treatment.
Company details
Akamara Biomedicine operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, therapeutics, and cancer treatment. Develops innovative therapeutics for cancer treatment. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters India
- SectorsHealthcare
- Website akamara.in
- Annual Revenue$413.96 K (USD)as on Mar 31, 2021
Associated legal entities of Akamara Biomedicine
Akamara Biomedicine is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Navam Technology Ventures Llp CIN AAM-9668 | Active | 13 Jul 2018 | Kolkata, West Bengal | $33 | 3 | View details | |
| Akamara Biomedicine Private Limited CIN U73100DL2017PTC322917 | Active | 30 Aug 2017 | Delhi, Delhi | ₹0.0 Cr | 37 | 4 | View details |
Board of directors of Akamara Biomedicine
The boards of the 2 registered companies of Akamara Biomedicine currently have 5 directors; the longest-serving is Raghunath Anant Mashelkar, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Raghunath Anant Mashelkar DIN 00074119 | Director | 30 Aug 2017 | 9 yrs 2 mo | Akamara Biomedicine Private Limited |
| Shiladitya Sengupta DIN 01837274 | Director | 30 Aug 2017 | 9 yrs 2 mo | Akamara Biomedicine Private Limited |
| Shrikant Mantri DIN 01240147 | Designated Partner | 13 Jul 2018 | 8 yrs 4 mo | Navam Technology Ventures Llp, Akamara Biomedicine Private Limited |
| Rajeev Mantri DIN 01895901 | Designated Partner | 13 Jul 2018 | 8 yrs 4 mo | Navam Technology Ventures Llp, Akamara Biomedicine Private Limited |
| Sonam Mantri DIN 08087804 | Designated Partner | 13 Jul 2018 | 8 yrs 4 mo | Navam Technology Ventures Llp |
Financials of Akamara Biomedicine
Figures of Akamara Biomedicine Private Limited, the primary company behind Akamara Biomedicine, for FY 2024. Revenue was ₹9,100 (-93% year on year). Net loss was -₹34,191 (-376% margin). EBITDA was -₹34,191 (-376% margin). Revenue has grown at a compounded annual rate of -93% over three years.
- ₹9,100Revenue · FY 2024 · -93% YoY
- -₹34,191Net loss · -376% margin
- -₹34,191EBITDA · -376% margin
- ₹1 LakhPaid-up capital
- 37Employees (provident fund records)
- -93%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Akamara Biomedicine Private Limited are on its company page.
Detailed financial statements for Akamara Biomedicine
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Akamara Biomedicine
Akamara Biomedicine was founded in 2019.
Akamara Biomedicine is headquartered in India.
Annual revenue of Akamara Biomedicine is $413.96K as on Mar 31, 2021.
Akamara Biomedicine operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, therapeutics, and cancer treatment. Develops innovative therapeutics for cancer treatment. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations. It continues to evolve, meeting industry challenges with strategic approaches.
Akamara Biomedicine is associated with 2 legal entities: Navam Technology Ventures Llp, Akamara Biomedicine Private Limited.
The legal entities of Akamara Biomedicine currently have 5 directors, including Shrikant Mantri, Rajeev Mantri, Sonam Mantri and others.